Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 12:31 AM UTC
| NCT Number | NCT06767514 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 780 participants |
| Active Locations | 89 sites in the US |
| Sponsor | Summit Therapeutics |
| Last Updated on CT.gov | February 24, 2026 (Feb 24, 2026) |
As of July 20, 2026: Clinical trial NCT06767514 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 89 locations across the United States. The study is sponsored by Summit Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06767514 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 89 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06767514 was last updated Feb 24, 2026 (February 24, 2026). HelloStudys verifies this status automatically.